近日,新加坡宣布启动一项价值1.3亿新元的RNA研究计划,旨在深化RNA在疫苗开发、疾病治疗和预防中的应用,进一步巩固新加坡在这一新兴领域的竞争力。 新加坡副总理、国家研究基金会主席王瑞杰( Heng Swee Keat)正式启动了一项新的国家计划,旨在使新加坡在 RNA 科学和应用进步方面处于领先地位。
国立研究基金会将在未来七年,拨款1亿3000万元开展新计划,促进核糖核酸的基础研究,探索相关疗法与新药如何改善癌症、心脏病、糖尿病等疾病。 副总理王瑞杰星期一(3月24日)宣布,启动全国核糖核酸生物学研究与应用计划(National ...
国立研究基金会在未来七年,将拨款1亿3000万元开展新计划,促进核糖核酸的基础研究,探索相关疗法与新药如何改善癌症、心脏病、糖尿病等疾病。 副总理王瑞杰星期一(3月24日)宣布,启动新加坡国家核糖核酸生物学研究与应用计划(National ...
Scientists at Oak Ridge National Laboratory have developed the first-ever method of detecting ribonucleic acid, or RNA, ...
The working principle of the ribonucleic acid (mRNA) vaccine, which played a role of 'relief pitcher' during the COVID-19 pandemic, has been revealed by a domestic research team. A research team led ...
Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...
ORNL scientists created a biosensor technology that lets researchers visualize and track RNA activity in living plants, using ...
The Republic aims to strengthen its RNA capabilities by providing a platform for key institutions here to collaborate. Read ...
A research team led by Rice University’s Yang Gao has uncovered new insights into the molecular mechanisms of ADAR1, a protein that regulates ribonucleic acid (RNA) induced immune responses. Their ...